Breathe Well Live Well
The Pharmaceutical Journal |
Pharmacy interventions improve asthma outcomes
The Pharmaceutical Journal They found that nine out of ten studies reporting current asthma control showed a positive impact from pharmacy interventions. Interventions were also associated with improvement of asthma severity in three studies and asthma symptoms in eight studies. |
View full post on asthma – Google News
Australian Journal of Pharmacy (registration) (blog) |
Late cold weather means asthma risk
Australian Journal of Pharmacy (registration) (blog) National Asthma Council Australia Director and pharmacist, Stephen Hughes, says that the delayed arrival of colder weather across Australia will hit unprepared families with asthma hard. “Our long stretch of warm temperatures into autumn is likely to … |
View full post on asthma – Google News
|
Twitter Could Help Predict and Prevent Asthma Flare-Ups
Pharmacy Times New research presented at the Pediatric Academic Societies 2016 Meeting suggests that health departments could use social media to prevent asthma flare-ups by distributing information about triggers to avoid and the importance of taking asthma … |
View full post on asthma – Google News
Australian Journal of Pharmacy (registration) (blog) |
Asthma: a breathtaking impact on life
Australian Journal of Pharmacy (registration) (blog) Woolcock Institute inhaler specialist (and pharmacist) Associate Professor Sinthia Bosnic-Anticevich says, “It is astonishing that despite the high level of asthma awareness in the community, so many people are compromising their well-being through … |
View full post on asthma – Google News
|
Dexamethasone for Asthma in the ER: Better Compliance
Pharmacy Practice News Adults with asthma who were treated with one dose of dexamethasone in the emergency department (ED) had only slightly higher relapse rates than patients who were treated with a five-day course of prednisone (Ann Emerg Med 2016 Apr 26. [Epub ahead … Single Dose of Dexamethasone for Asthma in the ER Non-Inferior to 5-Day Course of Prednisone One-dose of dexamethasone can improve outcomes of asthmatic patients in ER |
View full post on asthma – Google News
Medscape |
House dust mite immunotherapy in adults with allergic asthma
Pharmacy Today, American Pharmacists Association, pharmacist.com Taking house dust mite (HDM) sublingual allergen immunotherapy (SLIT) tablets in addition to maintenance medications appears to help reduce the risk of an attack in people with HDM allergy–related asthma. The double-blind, randomized study was … HDM SLIT tablet can reduce risk of moderate or severe asthma exacerbation Sublingual Immunotherapy Improves Dust Mite Allergy |
View full post on asthma – Google News
Online Athens |
People's Pharmacy: Some asthma diagnoses may be lung infection
Online Athens I used to take naproxen for the pain of a gout flare-up, but now I hear it can cause a problem with my Coumadin. Is there any safe anti-inflammatory medication that can be taken with Coumadin to help with the intense pain caused by gout flare-ups? Are … |
View full post on asthma – Google News
Australian Journal of Pharmacy (registration) (blog) |
OTC asthma preventers, restricted relievers proposed
Australian Journal of Pharmacy (registration) (blog) Experts alarmed at a possible figure of a million people with uncontrolled asthma have proposed major structural changes to the way asthma medicines are handled, including OTC preventers and restricting the OTC sale of relievers without preventers. |
View full post on asthma – Google News
Medscape |
FDA Approves Cinqair To Treat Severe Asthma
Pharmacy Practice News The FDA has approved reslizumab (Cinqair, Teva Pharmaceuticals) as an add-on maintenance treatment for patients aged 18 years and older with an eosinophilic phenotype asthma, who have a history of severe exacerbations despite receiving their current … FDA approves reslizumab to treat severe asthma Reslizumab (Cinqair) Approved to Treat Severe Asthma Cinqair Receives FDA Approval As Treatment For Severe Asthma |
View full post on asthma – Google News
Medscape |
FDA approves reslizumab to treat severe asthma
Pharmacy Today, American Pharmacists Association, pharmacist.com FDA has cleared reslizumab (Cinqair—Teva) for use with other asthma medicines for the maintenance treatment of severe asthma in adults. The drug is indicated for patients with a history of severe asthma attacks despite using their current asthma … FDA approves Cinqair to treat severe asthma Reslizumab (Cinqair) Approved to Treat Severe Asthma FDA Approves Teva's Asthma Injection to Treat Severe Asthma |
View full post on asthma – Google News